Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...

The Trump administration has unveiled yet another new payment model, this one focused on the cost of GLP-1 therapies. | The Trump administration has unveiled yet another new payment model, this one ...

Americans enrolled in Medicare will pay about 50% less out of pocket in 2026 for some drugs including Pfizer and Bristol ...

The Centers for Medicare & Medicaid Services (CMS) recently proposed the Guarding US Medicare Against Rising Drug Costs (GUARD) Model, a drug payment model that aims to distribute rebates for certain ...

The final rule takes effect Jan. 1. The AMA will be sharing with CMS its real-world impact. Here’s what it could mean for ...

The Centers for Medicare & Medicaid Services (CMS) is proposing a groundbreaking drug payment model to address the ...

Medicare enrollees could save roughly half of what they usually pay for certain drugs next year, according to a study from ...

Forbes contributors publish independent expert analyses and insights. Diane Omdahl is a Medicare expert who keeps her readers in the know. The Inflation Reduction Act is having quite an impact on 2025 ...

The rising cost for this coverage doesn’t appear to be happening in a vacuum, as health care costs in general are on the rise ...

Biomerica (BMRA) announced that the Centers for Medicare & Medicaid Services, CMS, has issued its final pricing determination for the company’s ...

A CMS pilot program will require providers in six states to submit select Medicare services for AI-enabled prior authorization or post-service medical review.

“GUARD is an innovative solution designed to bring Americans the drugs they need at prices they can better afford,” said CMS Innovation Center Director Abe Sutton. “No American should be forced to ...